Neuropace
NPCE
NASDAQ
IPO2021
about NPCE
Neuropace is a medical technology company that develops and manufactures advanced neural monitoring systems for use in neurosurgical procedures.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $13.75 | $14.15 | $13.53 | $467.31M | 194.29K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.11 | n/a | n/a | -9.51% | -12.78% | 0% |